Company intelligence / Profile preview
PrimeGen Biotech
Santa Ana, California, United States
- Ownership
- Private
- Employees
- ~17
- Development stage
- Other
01
Overview
PrimeGen US (formerly PrimeGen Biotech) is a California-based regenerative medicine company focused on developing innovative stem cell and exosome therapies. The company leverages its proprietary "Triple Activated" Mesenchymal Stem Cell (MSC) platform to treat acute and chronic inflammatory conditions, with a primary focus on liver diseases such as acute alcoholic hepatitis and acute liver failure. Founded in 2002, PrimeGen has spent nearly two decades in research and development, recently completing a Pre-IND meeting with the FDA to advance its lead candidate into clinical trials. In February 2026, the company announced a $1.5 billion business combination with DT Cloud Star Acquisition Corporation to transition to the public markets via a SPAC merger.
- Therapeutic areas
- EndocrinologyRheumatologyDermatologyGastroenterology
- Modalities
- Stem cell therapyCell therapyExosome-based therapy
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
Request access →03
Partnerships
RTI SurgicalDT Cloud Star Acquisition Corporation
Beyond the preview
Go deeper on PrimeGen Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PrimeGen Biotech.